Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,223 public trials 1,013 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00453154

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Carcinoma, +9 more
Locations
  • Arroyo Grande Community Arroyo Grande, California, United States
  • PCR Oncology Arroyo Grande, California, United States
  • East Bay Radiation Oncology Center Castro Valley, California, United States
  • Valley Medical Oncology Consultants-Castro Valley Castro Valley, California, United States
View all 125 locations
View Trial Details
Completed

Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies

NCT04181788

Conditions
Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Beijing Cancer hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
  • Huashan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China
View all 49 locations
View Trial Details
Completed

A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer

NCT03194893

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Centre Francois Baclesse Caen, France
  • Centre Georges François Leclerc Dijon, France
View all 29 locations
View Trial Details
Completed

A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

NCT03289962

Conditions
Bladder Cancer, Breast Diseases, Breast Neoplasms, +48 more
Locations
  • HonorHealth Research Institute ? Bisgrove Scottsdale, Arizona, United States
  • The Los Angeles Clinic Los Angeles, California, United States
  • UCSF Comprehensive Cancer Ctr San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 33 locations
View Trial Details
Completed

A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer

NCT04619797

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLA Los Angeles, California, United States
  • PIH Health Whittier Hospital Whittier, California, United States
  • SCRI Florida Cancer Specialists South Fort Myers, Florida, United States
  • SCRI Florida Cancer Specialists North St. Petersburg, Florida, United States
View all 127 locations
View Trial Details

Related conditions